Home > Financial Ratios > HESTER BIOSCIENCES

HESTER BIOSCIENCES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for HESTER BIOSCIENCES
Please provide your vote to see the results

HESTER BIOSCIENCES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 48.271.06-2.23-10.800.52

What is the latest Core EBITDA Growth ratio of HESTER BIOSCIENCES ?

The latest Core EBITDA Growth ratio of HESTER BIOSCIENCES is 48.27 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar202648.27
Mar20251.06
Mar2024-2.23
Mar2023-10.80
Mar20220.52

How is Core EBITDA Growth of HESTER BIOSCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2026 48.27
4,453.77
Mar2025 1.06
Positive
Mar2024 -2.23
Negative
Mar2023 -10.8
Negative
Mar2022 0.52 -

Other Financial Ratios of HESTER BIOSCIENCES


Compare Core EBITDA Growth ratio of peers of HESTER BIOSCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
HESTER BIOSCIENCES ₹1,743.0 Cr -8.5% -6% 25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


HESTER BIOSCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
HESTER BIOSCIENCES

-8.5%

-6%

25%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses